- Home
- HOLO vs BGLC Comparison
HOLO vs BGLC Comparison
Compare HOLO & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- BGLC
- Stock Information
- Founded
- HOLO 2018
- BGLC 2017
- Country
- HOLO China
- BGLC Malaysia
- Employees
- HOLO N/A
- BGLC N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- BGLC Medical Specialities
- Sector
- HOLO Technology
- BGLC Health Care
- Exchange
- HOLO Nasdaq
- BGLC Nasdaq
- Market Cap
- HOLO 95.5M
- BGLC 7.6M
- IPO Year
- HOLO N/A
- BGLC N/A
- Fundamental
- Price
- HOLO $4.47
- BGLC $0.37
- Analyst Decision
- HOLO
- BGLC
- Analyst Count
- HOLO 0
- BGLC 0
- Target Price
- HOLO N/A
- BGLC N/A
- AVG Volume (30 Days)
- HOLO 5.0M
- BGLC 117.9K
- Earning Date
- HOLO 10-29-2024
- BGLC 11-20-2024
- Dividend Yield
- HOLO N/A
- BGLC N/A
- EPS Growth
- HOLO N/A
- BGLC N/A
- EPS
- HOLO N/A
- BGLC N/A
- Revenue
- HOLO $32,242,196.00
- BGLC $9,183,168.00
- Revenue This Year
- HOLO N/A
- BGLC N/A
- Revenue Next Year
- HOLO N/A
- BGLC N/A
- P/E Ratio
- HOLO N/A
- BGLC N/A
- Revenue Growth
- HOLO 326.95
- BGLC N/A
- 52 Week Low
- HOLO $4.00
- BGLC $0.31
- 52 Week High
- HOLO $1,968.00
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- HOLO 41.41
- BGLC 32.80
- Support Level
- HOLO $4.83
- BGLC $0.38
- Resistance Level
- HOLO $6.01
- BGLC $0.49
- Average True Range (ATR)
- HOLO 0.92
- BGLC 0.02
- MACD
- HOLO -0.05
- BGLC -0.01
- Stochastic Oscillator
- HOLO 4.86
- BGLC 5.94
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.